Reply to "Correspondence to Economic and Clinical Considerations for NC-MRI in Late HCC Recurrence Surveillance"

Qi-Feng Chen1, Sui-Xing Zhong2, Xiong-Ying Jiang3

  • 1Department of Minimally Invasive Interventional Therapy, Liver Cancer Study and Service Group, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China.

Abstract

No abstract available in PubMed .

Related Concept Videos